期刊
NEUROLOGY
卷 80, 期 21, 页码 1989-1996出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e318293e2ce
关键词
-
资金
- Lundbeck
- Prana Biotechnology
- Macklin Foundation
- Robert Wood Johnson Foundation
- Agency for Health Care Research and Quality [HS018960-01]
- Parkinson's Disease Foundation [PDF-SFW-1204]
- American Academy of Neurology
- National Institute on Aging
- New York Academy of Medicine
- Johns Hopkins University
- John A. Hartford Foundation
- Atlantic Philanthropies
- National Institute of Aging
- National Quality Forum
As the US population ages, the burden of neurodegenerative disorders, including Alzheimer disease and Parkinson disease, will increase substantially. However, many of these patients and their families currently do not receive neurologic care. For example, a recent study found that over 40% of Medicare beneficiaries with an incident Parkinson disease diagnosis did not receive neurologist care early after diagnosis and those who did not were more likely to fracture a hip, be placed in a nursing home, and die. While geography, age, race, and sex likely contribute to these observed disparities in care and outcomes, a large barrier may be Medicare's reimbursement policies, which value procedures over care. With further reductions in Medicare reimbursement constantly on the horizon, the devaluing of clinical care will likely continue. Rather than guaranteeing access to care, Medicare's reimbursement policies may increasingly be an impediment to care. Neurology (R) 2013;80:1989-1996
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据